Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Forte Biosciences, Inc. | fbrx-ex321_10.htm |
| EX-31.2 - EX-31.2 - Forte Biosciences, Inc. | fbrx-ex312_8.htm |
| EX-31.1 - EX-31.1 - Forte Biosciences, Inc. | fbrx-ex311_6.htm |
| 10-Q - 10-Q - Forte Biosciences, Inc. | fbrx-10q_20200930.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Antony Riley, the Chief Financial Officer of Forte Biosciences, Inc. (the "Company"), certify for the purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
|
|
(1) |
The Quarterly Report of the Company on Form 10-Q for the three months ended September 30, 2020 (the "Report"), fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and |
|
|
(2) |
The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
|
Date: November 9, 2020 |
By: |
|
/s/ Antony Riley |
|
|
|
|
Antony Riley |
|
|
|
|
Chief Financial Officer |